Tag: ENERGENESIS BIOMEDICAL CO.

Energenesis Biomedical to Unveil Promising Parkinson’s Disease Therapy, ENERGI-F705PD, at BIO International 2025

TAIPEI, June 11, 2025 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company pioneering cellular energy restoration therapeutics, today announced its...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsENERGENESIS BIOMEDICAL CO.

AsiaPay Partners with Tai Wo Management to Launch JOIE digital Payment Solution, Enhancing the Taxi Experience in Hong Kong

KBR ALERT: Bragar Eagel & Squire, P.C. is Investigating KBR, Inc. on Behalf of KBR Stockholders and Encourages Investors to Contact the Firm

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Tag: ENERGENESIS BIOMEDICAL CO.

Energenesis Biomedical to Unveil Promising Parkinson’s Disease Therapy, ENERGI-F705PD, at BIO International 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us